HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Metolazone

HCID 4170
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
17560-51-9
Standard SMILES
Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C
InChIKey
AQCHWTWZEMGIFD-UHFFFAOYSA-N
Molecular formula
C16H16ClN3O3S
Average molar mass
365.8 g/mol
Monoisotopic mass
365.0600902

Overview

Metolazone is a quinazoline that consists of 1,2,3,4-tetrahydroquinazolin-4-one bearing additional methyl, 2-tolyl, sulfamyl and chloro substituents at positions 2, 3, 6 and 7 respectively. A quinazoline diuretic, with properties similar to thiazide diuretics. It has a role as a diuretic, an antihypertensive agent and an ion transport inhibitor. It is a sulfonamide, an organochlorine compound and a member of quinazolines.

Names & identifiers

Preferred name
Metolazone
IUPAC
7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
English name
metolazone
Molecular formula
C16H16ClN3O3S
Molecular weight
365.83

Names & synonyms

metolazone17560-51-9ZaroxolynDiuloMykroxOldrenMetenixMetalozoneMetolazonaMetolazonummetozaloneNormelan
Show more names
XuretSR 720-227-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamideSR-720-22Metazoline6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-DTXSID60451677-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide

Database identifiers

CAS
17560-51-9、56436-31-8、56436-32-9
PubChem CID
4170
DTXSID
DTXSID6045167
ChEMBL
CHEMBL878
ChEBI
CHEBI:64354
UNII
NM7V2Y3G0U、NN9U607695、TZ7V40X7VX
EC Number
241-539-3
Nikkaji
J3.450I

Properties

Computed structural propertiesFilling in

XLogP
4.1
Topological polar surface area
101 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
2
Heavy atoms
24
Formal charge
0
Complexity
594

Experimental & physicochemical properties

LogP · 2 items

2.5

1.8

OdorODORLESS
TasteTASTELESS
Color/FormCRYSTALS FROM ETHANOL
Solubility · 2 items

INSOL IN WATER & ALCOHOL

4.07e-02 g/L

Human Drugs · 4 items

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Thiazide Diuretics

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Melting Point · 2 items

253-259 °C

256 °C

Physical DescriptionSolid
Stability/Shelf LifeLIGHT-SENSITIVE

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Toxicology

Interactions · 5 items

...METOLAZONE...CHEMICALLY & PHARMACOLOGICALLY RELATED TO THIAZIDE DIURETICS & ELEVATE SERUM URATE LEVELS. ...MAY...INTERACT WITH PROBENECID.

USE OF THIAZIDE DIURETIC MAY IMPAIR CONTROL OF DIABETES IN PT TREATED...WITH ORAL HYPOGLYCEMIC AGENTS OR INSULIN, BUT ONLY TO LIMITED EXTENT. /THIAZIDE DIURETICS/

METOLAZONE...STRUCTURALLY RELATED TO THIAZIDE DIURETICS, CAN CAUSE HYPOKALEMIA, & MAY BE EXPECTED TO INTERACT WITH CARDIAC GLYCOSIDES.

THIAZIDES ENHANCE ANTIHYPERTENSIVE ACTION OF GUANETHIDINE... /THIAZIDE DIURETICS/

For more Interactions (Complete) data for METOLAZONE (6 total), please visit the HSDB record page.

Adverse Effects · 1 item

Hyperuricemia is a common adverse effect due to competitive inhibition of uric acid secretion and a decrease in extracellular fluid from diuretic effects. Other fluid and electrolyte imbalances may occur, especially hyponatremia, hypokalemia, and hypomagnesemia. Any electrolyte imbalances must be corrected before starting treatment. Metolazone may impair glucose tolerance, causing hyperglycemia and glycosuria. Diabetic patients should monitor their blood and urine glucose levels while on this therapy.

Chemistry & industry

Pharmacology

ATC Code · 2 items

C - Cardiovascular system

QC - Cardiovascular system

Protein Binding50-70% bound to erythrocytes, up to 33% bound to plasma proteins, 2-5% of the drug in circulation is unbound
Pharmacodynamics · 1 item

Metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. A proximal action of metolazone has been shown in humans by increased excretion of phosphate and magnesium ions and by a markedly increased fractional excretion of sodium in patients with severely compromised glomerular filtration. This action has been demonstrated in animals by micropuncture studies.

Mechanism of Action · 2 items

The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption. Metolazone acts primarily to inhibit sodium reabsorption at the cortical diluting site and to a lesser extent in the proximal convoluted tubule. Sodium and chloride ions are excreted in approximately equivalent amounts. The increased delivery of sodium to the distal tubular exchange site results in increased potassium excretion. Metolazone does not inhibit carbonic anhydrase. The antihypertensive mechanism of action of metolazone is not fully understood but is presumed to be related to its saluretic and diuretic properties.

IT ACTS PRIMARILY TO INHIBIT SODIUM REABSORPTION AT CORTICAL DILUTING SITE & IN PROXIMAL CONVOLUTED TUBULE. SODIUM & CHLORIDE IONS ARE EXCRETED IN APPROX EQUAL AMT; INCR POTASSIUM EXCRETION MAY ALSO OCCUR. DIURETIC POTENCY APPROXIMATES THAT OF THIAZIDES.

Biological Half-Life · 3 items

Approximately 14 hours.

LONG T/2 VALUE...IN DOGS IS RELATED TO TRANSPORT MECHANISM IN BLOOD & PARTITION BETWEEN FORMED ELEMENTS & SERUM PROTEINS.

...METOLAZONE IS EXCRETED BY GLOMERULAR FILTRATION & TUBULAR SECRETION IN DOGS, ALTHOUGH DRUG:CREATININE CLEARANCE RATIO IS LOWER THAN FOR MOST OTHER DIURETICS. T/2 IN DOGS OF 5-6 HR IS INFLUENCED BY EXTENSIVE BINDING TO ERYTHROCYTES & PLASMA PROTEINS, & POSSIBLY TO TISSUE PROTEINS.

Related reactions

1 records
New reaction record
HRID 1781246 reaction equation
HRID 1781246As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Dissociation Constants
PKA: 9.72
Collision Cross Section · 2 items

181.2 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

166.87 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Other Experimental Properties · 3 items

ALSO REPORTED AS MP 246-250 °C (US PATENT 3,557,111)

PREVIOUSLY REPORTED AS POLYMORPHIC SOLID WITH MP RANGE 218-259 °C

TWO MAJOR POLYMORPHS ARE FORMED AS NOTED BY ENDOTHERMS @ ABOUT 227.5 °C & 276.5 °C

Physicochemical properties

Boiling point
613.6 · 613.6±65.0 °C(Predicted)
Density
1.4 · 1.400±0.06 g/cm3(Predicted)
pka
10 · 10.00±0.60(Predicted)
FDA UNII
9 U607695 · NN9U607695
Toxicity Summary · 1 item

For diuretics in general, toxic doses are not well established. Chronic use is the most common cause of toxicity, such as hypotension and increased hematocrit due to plasma volume depletion and syncope. Hypokalemia, hyponatremia and reduced renal function, and increased mortality have been reported with the use of metolazone. Sodium levels should be corrected according to serum glucose levels.

Human Toxicity Excerpts · 2 items

ADVERSE EFFECTS... ANOREXIA, GASTRIC IRRITATION, NAUSEA, VOMITING, CRAMPING, DIARRHEA, JAUNDICE, PANCREATITIS, SIALADENITIS, DIZZINESS, VERTIGO, PARESTHESIAS, HEADACHE, XANTHOPSIA, LEUKOPENIA, AGRANULOCYTOSIS, THROMBOCYTOPENIA, APLASTIC ANEMIA, ORTHOSTATIC HYPOTENSION. /THIAZIDES/

ADVERSE EFFECTS... PURPURA, PHOTOSENSITIVITY, RASH, URTICARIA, NECROTIZING ANGITIS, FEVER, RESPIRATORY DISTRESS, ANAPHYLACTIC REACTIONS, HYPERGLYCEMIA, GLYCOSURIA, HYPERURICEMIA, MUSCLE SPASM, WEAKNESS, RESTLESSNESS, BLURRED VISION, & HEMATURIA. /THIAZIDES/

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Metolazone

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Non-Human Toxicity Values · 2 items

LD50 MICE ORAL MORE THAN 5000 MG/KG

LD50 MICE INTRAPERITONEAL MORE THAN 1500 MG/KG

Metabolism/Metabolites · 2 items

Not substantially metabolized. 70-95% is excreted unchanged in urine via glomerular filtration and active tubular secretion. Undergoes enterohepatic recycling.

SEVENTY-FIVE PER CENT OF DOSE /ADMIN TO DOGS/ IS EXCRETED IN URINE & 25% IN BILE. 60%...AS HYDROXYLATED DERIV...& FURTHER PRODUCTS OF OXIDN...& UNIDENTIFIED POLAR METABOLITES ARE ALSO PRESENT IN URINE.

FDA Pharmacological Classification · 6 items

TZ7V40X7VX

METOLAZONE

Physiologic Effects [PE] - Increased Diuresis

Established Pharmacologic Class [EPC] - Thiazide-like Diuretic

Metolazone is a Thiazide-like Diuretic. The physiologic effect of metolazone is by means of Increased Diuresis.

METOLAZONE

MeSH Pharmacological Classification · 3 items

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Agents that promote the excretion of urine through their effects on kidney function.

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.

Absorption, Distribution and Excretion · 4 items

Peak blood levels are obtained within 2 to 4 hours of oral administration. The rate and extent of absorption are formulation dependent.

Most of the drug is excreted in the unconverted form in the urine.

75% OF DOSE /ADMIN TO DOGS/ ...EXCRETED IN URINE & 25% IN BILE. 60%...AS HYDROXYLATED DERIV...& FURTHER PRODUCTS OF OXIDN...& UNIDENTIFIED POLAR METABOLITES ARE ALSO PRESENT IN URINE.

RENAL CLEARANCES OF.../THIAZIDE DIURETICS/ ARE...HIGH. MOST COMPOUNDS ARE RAPIDLY EXCRETED WITHIN 3-6 HR. BENDROFLUMETHIAZIDE & POLYTHIAZIDE HAVE LONGER DURATION OF ACTION THAT IS CORRELATED WITH SLOWER EXCRETION... SAME IS TRUE OF...METOLAZONE.

Cellular LocationsMembrane
Metabolite PathwaysMetolazone Action Pathway

Uses & manufacturing

UsesMEDICATION
Methods of Manufacturing · 2 items

SHETTY, US PATENTS 3,360,518 (1967 TO WALLACE & TIERNAN) AND 3,557,111 (1971); SHETTY ET AL, J MED CHEM 13, 886 (1970).

5-CHLORO-O-TOLUIDINE IS CONVERTED THROUGH SERIES OF REACTIONS INTO N-(O-TOLYL)-2-AMINO-4-CHLORO-5-SULFAMOYLBENZAMIDE WHICH IS CAUSED TO UNDERGO RING CLOSURE THROUGH REACTION WITH ACETALDEHYDE. US PATENT 3,360,518.

Formulations/PreparationsZAROXOLYN (PENNWALT), TABLETS 2.5, 5, & 10 MG.
Use ClassificationPharmaceuticals
Additional notes · 1 item

DefinitionChEBI: Metolazone is a quinazoline that consists of 1,2,3,4-tetrahydroquinazolin-4-one bearing additional methyl, 2-tolyl, sulfamyl and chloro substituents at positions 2, 3, 6 and 7 respectively. A quinazoline diuretic, with properties similar to thiazide diuretics. It has a role as a diuretic, an antihypertensive agent and an ion transport inhibitor. It is a member of quinazolines, an organochlorine compound and a sulfonamide.